MARKET INTRODUCTION
Anti- Neoplastic agents are the agents which are used to treat various types of cancers as well as malignancies. These agents act by inhibiting the proliferation and maturation of neoplasm. Antineoplastic agents are also known as chemotherapy agents, cytotoxic agents, anticancer agents etc. These antineoplastic agents nearly used in all type of cancer as a part of chemotherapy in combination or alone. Many of antineoplastic agents are injected in body in liquid form but sometimes patients also need to take them orally in form of tablets.
MARKET DYNAMICS
The key market drivers for Anti - Neoplastic Agents Market Includes, rising prevalence of malignancies and cancers globally along with rising incidences of blood and blood related disorders. Additionally, Strong R&D investments by pharmaceutical companies for development of novel therapies is also expected to boost market growth during the forecast period. However, potential side effects after chemotherapeutic agents along with high cost of developing antineoplastic agents is expected to restrain market growth during forecast period.
MARKET SCOPE
The "Anti - Neoplastic Agents Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti - Neoplastic Agents market with detailed market segmentation by type and end user. The Anti - Neoplastic Agents Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Anti - Neoplastic Agents Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Anti - Neoplastic Agents Market is segmented on the basis of type and end user. On the basis of type the market is segmented on the basis of alkylating agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents and miscellaneous agents. And on the basis of end user market is segmented as, hospitals, clinics, research institutes, cancer rehabilitation centers and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Anti - Neoplastic Agents Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti - Neoplastic Agents Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Anti - Neoplastic Agents Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti - Neoplastic Agents Market in these regions.
MARKET PLAYERS
The report covers key developments in the Anti - Neoplastic Agents Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Anti - Neoplastic Agents Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Anti - Neoplastic Agents market in the global market. Below mentioned is the list of few companies engaged in the Anti - Neoplastic Agents Market.
The report also includes the profiles of key players in Anti - Neoplastic Agents Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
Amgen, Inc.
Boehringer Ingelheim GmbH
Bayer AG
Bristol-Myers Squibb Company
F. Hoffmann- La Roche AG
Aspen Holdings
Pfizer Inc.
Baxter Healthcare Corporation
Teva Pharmaceutical Industries Ltd.
Genentech Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti - Neoplastic Agents Market - By Type
1.3.2 Anti - Neoplastic Agents Market - By End User
1.3.3 Anti - Neoplastic Agents Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI - NEOPLASTIC AGENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI - NEOPLASTIC AGENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI - NEOPLASTIC AGENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI - NEOPLASTIC AGENTS - GLOBAL MARKET OVERVIEW
6.2. ANTI - NEOPLASTIC AGENTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI - NEOPLASTIC AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALKYLATING AGENTS
7.3.1. Overview
7.3.2. Alkylating agents Market Forecast and Analysis
7.4. ANTIMETABOLITES
7.4.1. Overview
7.4.2. antimetabolites Market Forecast and Analysis
7.5. ANTITUMOR ANTIBIOTICS
7.5.1. Overview
7.5.2. antitumor antibiotics Market Forecast and Analysis
7.6. PLANT ALKALOIDS
7.6.1. Overview
7.6.2. plant alkaloids Market Forecast and Analysis
7.7. HORMONAL AGENTS
7.7.1. Overview
7.7.2. hormonal agents Market Forecast and Analysis
7.8. MISCELLANEOUS AGENTS
7.8.1. Overview
7.8.2. miscellaneous agents Market Forecast and Analysis
8. ANTI - NEOPLASTIC AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. clinics Market Forecast and Analysis
8.5. RESEARCH INSTITUTES
8.5.1. Overview
8.5.2. research institutes Market Forecast and Analysis
8.6. CANCER REHABILITATION CENTERS
8.6.1. Overview
8.6.2. cancer rehabilitation centers Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. ANTI - NEOPLASTIC AGENTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti - Neoplastic Agents Market Overview
9.1.2 North America Anti - Neoplastic Agents Market Forecasts and Analysis
9.1.3 North America Anti - Neoplastic Agents Market Forecasts and Analysis - By Type
9.1.4 North America Anti - Neoplastic Agents Market Forecasts and Analysis - By End User
9.1.5 North America Anti - Neoplastic Agents Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti - Neoplastic Agents Market
9.1.5.1.1 United States Anti - Neoplastic Agents Market by Type
9.1.5.1.2 United States Anti - Neoplastic Agents Market by End User
9.1.5.2 Canada Anti - Neoplastic Agents Market
9.1.5.2.1 Canada Anti - Neoplastic Agents Market by Type
9.1.5.2.2 Canada Anti - Neoplastic Agents Market by End User
9.1.5.3 Mexico Anti - Neoplastic Agents Market
9.1.5.3.1 Mexico Anti - Neoplastic Agents Market by Type
9.1.5.3.2 Mexico Anti - Neoplastic Agents Market by End User
9.2. EUROPE
9.2.1 Europe Anti - Neoplastic Agents Market Overview
9.2.2 Europe Anti - Neoplastic Agents Market Forecasts and Analysis
9.2.3 Europe Anti - Neoplastic Agents Market Forecasts and Analysis - By Type
9.2.4 Europe Anti - Neoplastic Agents Market Forecasts and Analysis - By End User
9.2.5 Europe Anti - Neoplastic Agents Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti - Neoplastic Agents Market
9.2.5.1.1 Germany Anti - Neoplastic Agents Market by Type
9.2.5.1.2 Germany Anti - Neoplastic Agents Market by End User
9.2.5.2 France Anti - Neoplastic Agents Market
9.2.5.2.1 France Anti - Neoplastic Agents Market by Type
9.2.5.2.2 France Anti - Neoplastic Agents Market by End User
9.2.5.3 Italy Anti - Neoplastic Agents Market
9.2.5.3.1 Italy Anti - Neoplastic Agents Market by Type
9.2.5.3.2 Italy Anti - Neoplastic Agents Market by End User
9.2.5.4 Spain Anti - Neoplastic Agents Market
9.2.5.4.1 Spain Anti - Neoplastic Agents Market by Type
9.2.5.4.2 Spain Anti - Neoplastic Agents Market by End User
9.2.5.5 United Kingdom Anti - Neoplastic Agents Market
9.2.5.5.1 United Kingdom Anti - Neoplastic Agents Market by Type
9.2.5.5.2 United Kingdom Anti - Neoplastic Agents Market by End User
9.2.5.6 Rest of Europe Anti - Neoplastic Agents Market
9.2.5.6.1 Rest of Europe Anti - Neoplastic Agents Market by Type
9.2.5.6.2 Rest of Europe Anti - Neoplastic Agents Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti - Neoplastic Agents Market Overview
9.3.2 Asia-Pacific Anti - Neoplastic Agents Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti - Neoplastic Agents Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Anti - Neoplastic Agents Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Anti - Neoplastic Agents Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti - Neoplastic Agents Market
9.3.5.1.1 Australia Anti - Neoplastic Agents Market by Type
9.3.5.1.2 Australia Anti - Neoplastic Agents Market by End User
9.3.5.2 China Anti - Neoplastic Agents Market
9.3.5.2.1 China Anti - Neoplastic Agents Market by Type
9.3.5.2.2 China Anti - Neoplastic Agents Market by End User
9.3.5.3 India Anti - Neoplastic Agents Market
9.3.5.3.1 India Anti - Neoplastic Agents Market by Type
9.3.5.3.2 India Anti - Neoplastic Agents Market by End User
9.3.5.4 Japan Anti - Neoplastic Agents Market
9.3.5.4.1 Japan Anti - Neoplastic Agents Market by Type
9.3.5.4.2 Japan Anti - Neoplastic Agents Market by End User
9.3.5.5 South Korea Anti - Neoplastic Agents Market
9.3.5.5.1 South Korea Anti - Neoplastic Agents Market by Type
9.3.5.5.2 South Korea Anti - Neoplastic Agents Market by End User
9.3.5.6 Rest of Asia-Pacific Anti - Neoplastic Agents Market
9.3.5.6.1 Rest of Asia-Pacific Anti - Neoplastic Agents Market by Type
9.3.5.6.2 Rest of Asia-Pacific Anti - Neoplastic Agents Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti - Neoplastic Agents Market Overview
9.4.2 Middle East and Africa Anti - Neoplastic Agents Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti - Neoplastic Agents Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Anti - Neoplastic Agents Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Anti - Neoplastic Agents Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti - Neoplastic Agents Market
9.4.5.1.1 South Africa Anti - Neoplastic Agents Market by Type
9.4.5.1.2 South Africa Anti - Neoplastic Agents Market by End User
9.4.5.2 Saudi Arabia Anti - Neoplastic Agents Market
9.4.5.2.1 Saudi Arabia Anti - Neoplastic Agents Market by Type
9.4.5.2.2 Saudi Arabia Anti - Neoplastic Agents Market by End User
9.4.5.3 U.A.E Anti - Neoplastic Agents Market
9.4.5.3.1 U.A.E Anti - Neoplastic Agents Market by Type
9.4.5.3.2 U.A.E Anti - Neoplastic Agents Market by End User
9.4.5.4 Rest of Middle East and Africa Anti - Neoplastic Agents Market
9.4.5.4.1 Rest of Middle East and Africa Anti - Neoplastic Agents Market by Type
9.4.5.4.2 Rest of Middle East and Africa Anti - Neoplastic Agents Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti - Neoplastic Agents Market Overview
9.5.2 South and Central America Anti - Neoplastic Agents Market Forecasts and Analysis
9.5.3 South and Central America Anti - Neoplastic Agents Market Forecasts and Analysis - By Type
9.5.4 South and Central America Anti - Neoplastic Agents Market Forecasts and Analysis - By End User
9.5.5 South and Central America Anti - Neoplastic Agents Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti - Neoplastic Agents Market
9.5.5.1.1 Brazil Anti - Neoplastic Agents Market by Type
9.5.5.1.2 Brazil Anti - Neoplastic Agents Market by End User
9.5.5.2 Argentina Anti - Neoplastic Agents Market
9.5.5.2.1 Argentina Anti - Neoplastic Agents Market by Type
9.5.5.2.2 Argentina Anti - Neoplastic Agents Market by End User
9.5.5.3 Rest of South and Central America Anti - Neoplastic Agents Market
9.5.5.3.1 Rest of South and Central America Anti - Neoplastic Agents Market by Type
9.5.5.3.2 Rest of South and Central America Anti - Neoplastic Agents Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTI - NEOPLASTIC AGENTS MARKET, KEY COMPANY PROFILES
11.1. AMGEN INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. F. HOFFMANN-LA ROCHE LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAYER AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASPEN HOLDINGS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BRISTOL-MYERS SQUIBB COMPANY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BAXTER HEALTHCARE CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GENENTECH INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Amgen Inc.
2. Boehringer Ingelheim GmbH
3. F. Hoffmann-La Roche Ltd
4. Bayer AG
5. Aspen Holdings
6. Pfizer Inc.
7. Bristol-Myers Squibb Company
8. Baxter Healthcare Corporation
9. Teva pharmaceutical Industries Ltd.
10. Genentech Inc